Teacher Retirement System of Texas reduced its position in Balchem Co. (NASDAQ:BCPC – Free Report) by 26.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 31,201 shares of the basic materials company’s stock after selling 11,269 shares during the period. Teacher Retirement System of Texas owned about 0.10% of Balchem worth $5,086,000 as of its most recent SEC filing.
Several other institutional investors have also made changes to their positions in BCPC. FMR LLC increased its position in shares of Balchem by 944.3% in the third quarter. FMR LLC now owns 497,495 shares of the basic materials company’s stock worth $87,559,000 after acquiring an additional 449,854 shares in the last quarter. Proficio Capital Partners LLC purchased a new position in shares of Balchem in the fourth quarter worth approximately $23,628,000. Raymond James Financial Inc. purchased a new position in shares of Balchem in the fourth quarter worth approximately $13,359,000. Barclays PLC increased its position in shares of Balchem by 405.8% in the third quarter. Barclays PLC now owns 60,777 shares of the basic materials company’s stock worth $10,695,000 after acquiring an additional 48,762 shares in the last quarter. Finally, Geneva Capital Management LLC increased its position in shares of Balchem by 5.1% in the fourth quarter. Geneva Capital Management LLC now owns 819,746 shares of the basic materials company’s stock worth $133,615,000 after acquiring an additional 39,877 shares in the last quarter. 87.91% of the stock is owned by hedge funds and other institutional investors.
Balchem Stock Performance
Shares of BCPC opened at $161.17 on Monday. The company’s 50 day moving average price is $164.71 and its 200 day moving average price is $169.40. Balchem Co. has a 52 week low of $137.69 and a 52 week high of $186.03. The company has a market capitalization of $5.24 billion, a PE ratio of 41.01, a PEG ratio of 4.41 and a beta of 0.63. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.16 and a current ratio of 1.99.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on BCPC shares. Sidoti raised shares of Balchem to a “hold” rating in a research report on Tuesday, February 25th. StockNews.com downgraded shares of Balchem from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $190.00 price objective on shares of Balchem in a research report on Monday, February 24th.
Get Our Latest Report on Balchem
About Balchem
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
See Also
- Five stocks we like better than Balchem
- Investing In Preferred Stock vs. Common Stock
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Consumer Discretionary Stocks Explained
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Free Report).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.